SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 223 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5 | 0.0% | 187 | +11.3% | 0.00% | – |
| Q2 2023 | $5 | -58.3% | 168 | -50.4% | 0.00% | – |
| Q1 2023 | $12 | +20.0% | 339 | +27.0% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 267 | -5.3% | 0.00% | – |
| Q3 2022 | $10,000 | +100.0% | 282 | +54.1% | 0.00% | – |
| Q2 2022 | $5,000 | -16.7% | 183 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | 0.0% | 183 | -9.0% | 0.00% | – |
| Q4 2021 | $6,000 | +200.0% | 201 | +240.7% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | – | 59 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |